Samsung C&T Toekomstige groei
Future criteriumcontroles 1/6
Samsung C&T zal naar verwachting groeien in winst en omzet met respectievelijk 8.4% en 1.9% per jaar. De winst per aandeel zal naar verwachting groeien met 7.1% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 6.7% zijn.
Belangrijke informatie
8.4%
Groei van de winst
7.1%
Groei van de winst per aandeel
Industrials winstgroei | 38.1% |
Inkomstengroei | 1.9% |
Toekomstig rendement op eigen vermogen | 6.7% |
Dekking van analisten | Good |
Laatst bijgewerkt | 02 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Earnings Not Telling The Story For Samsung C&T Corporation (KRX:028260)
Oct 22Is Samsung C&T (KRX:028260) A Risky Investment?
Oct 01We Like These Underlying Return On Capital Trends At Samsung C&T (KRX:028260)
Sep 10A Look At The Intrinsic Value Of Samsung C&T Corporation (KRX:028260)
Jul 11We Think Samsung C&T (KRX:028260) Can Stay On Top Of Its Debt
Jun 22Improved Earnings Required Before Samsung C&T Corporation (KRX:028260) Shares Find Their Feet
Jun 05We Like These Underlying Return On Capital Trends At Samsung C&T (KRX:028260)
May 21Is Now The Time To Put Samsung C&T (KRX:028260) On Your Watchlist?
Apr 20Samsung C&T (KRX:028260) Seems To Use Debt Quite Sensibly
Mar 15Samsung C&T Corporation (KRX:028260) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Feb 27Why Samsung C&T Corporation (KRX:028260) Could Be Worth Watching
Mar 31Is Samsung C&T Corporation (KRX:028260) A Smart Pick For Income Investors?
Mar 16Will Samsung C&T's (KRX:028260) Growth In ROCE Persist?
Mar 01These 4 Measures Indicate That Samsung C&T (KRX:028260) Is Using Debt Reasonably Well
Feb 13Can You Imagine How Samsung C&T's (KRX:028260) Shareholders Feel About The 20% Share Price Increase?
Jan 31Is There An Opportunity With Samsung C&T Corporation's (KRX:028260) 27% Undervaluation?
Jan 18What Type Of Shareholders Make Up Samsung C&T Corporation's (KRX:028260) Share Registry?
Jan 05Is It Smart To Buy Samsung C&T Corporation (KRX:028260) Before It Goes Ex-Dividend?
Dec 24Is There Now An Opportunity In Samsung C&T Corporation (KRX:028260)?
Dec 18Samsung C&T Corporation (KRX:028260) Vies For A Place In Your Dividend Portfolio: Here's Why
Dec 05We Like These Underlying Trends At Samsung C&T (KRX:028260)
Nov 22Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 44,811,073 | 2,756,625 | 3,410,080 | 3,784,460 | 15 |
12/31/2025 | 43,190,294 | 2,506,281 | 2,915,350 | 3,463,746 | 17 |
12/31/2024 | 42,130,238 | 2,335,030 | 1,771,633 | 2,534,925 | 13 |
6/30/2024 | 42,871,544 | 2,230,709 | 1,811,051 | 2,879,490 | N/A |
3/31/2024 | 42,452,881 | 2,242,539 | 715,644 | 1,789,408 | N/A |
12/31/2023 | 41,895,681 | 2,198,323 | 1,382,828 | 2,798,653 | N/A |
9/30/2023 | 42,443,675 | 2,298,127 | 1,376,350 | 2,709,753 | N/A |
6/30/2023 | 42,728,098 | 2,228,235 | 2,513,349 | 3,940,092 | N/A |
3/31/2023 | 42,960,554 | 2,159,928 | 2,208,330 | 3,640,845 | N/A |
12/31/2022 | 43,161,653 | 2,044,080 | 1,373,434 | 2,618,286 | N/A |
9/30/2022 | 42,278,846 | 1,784,034 | 384,092 | 1,454,210 | N/A |
6/30/2022 | 39,326,273 | 1,582,944 | -994,809 | -127,641 | N/A |
3/31/2022 | 37,055,284 | 1,325,399 | 192,126 | 998,649 | N/A |
12/31/2021 | 34,455,182 | 1,635,046 | 614,847 | 1,195,732 | N/A |
9/30/2021 | 32,872,597 | 1,656,804 | 1,275,501 | 1,818,632 | N/A |
6/30/2021 | 32,419,886 | 1,652,879 | 1,137,796 | 1,634,601 | N/A |
3/31/2021 | 31,095,612 | 1,584,119 | 821,714 | 1,203,039 | N/A |
12/31/2020 | 30,216,119 | 1,035,495 | 947,571 | 1,267,897 | N/A |
9/30/2020 | 29,731,634 | 1,134,724 | 1,031,889 | 1,340,360 | N/A |
6/30/2020 | 29,615,927 | 1,091,959 | 1,452,706 | 1,762,807 | N/A |
3/31/2020 | 30,364,542 | 1,123,194 | 513,564 | 847,139 | N/A |
12/31/2019 | 30,761,501 | 1,050,076 | 362,409 | 770,850 | N/A |
9/30/2019 | 31,034,745 | 1,376,486 | 207,740 | 712,508 | N/A |
6/30/2019 | 31,080,605 | 1,410,808 | -233,514 | 283,430 | N/A |
3/31/2019 | 31,036,367 | 1,542,605 | 546,083 | 1,120,884 | N/A |
12/31/2018 | 31,155,637 | 1,697,477 | 1,076,151 | 1,678,377 | N/A |
9/30/2018 | 30,949,384 | 1,193,027 | 1,066,030 | 1,641,207 | N/A |
6/30/2018 | 30,661,547 | 1,062,336 | 1,240,890 | 1,864,011 | N/A |
3/31/2018 | 30,053,065 | 829,825 | N/A | 1,214,754 | N/A |
12/31/2017 | 29,279,046 | 639,798 | N/A | 1,312,436 | N/A |
9/30/2017 | 29,457,603 | 716,014 | N/A | 226,250 | N/A |
6/30/2017 | 28,586,444 | 734,048 | N/A | 376,868 | N/A |
3/31/2017 | 28,317,946 | 770,998 | N/A | 1,479,373 | N/A |
12/31/2016 | 28,102,684 | 106,329 | N/A | 1,355,395 | N/A |
9/30/2016 | 27,380,385 | -261,808 | N/A | 1,542,185 | N/A |
6/30/2016 | 24,298,136 | 2,470,650 | N/A | 1,350,059 | N/A |
3/31/2016 | 18,558,879 | 2,284,757 | N/A | 323,031 | N/A |
12/31/2015 | 13,344,675 | 2,746,812 | N/A | -62,348 | N/A |
9/30/2015 | 7,638,197 | 2,909,010 | N/A | 145,468 | N/A |
6/30/2015 | 5,320,893 | 25,214 | N/A | 142,986 | N/A |
3/31/2015 | 5,248,922 | 81,094 | N/A | 90,550 | N/A |
12/31/2014 | 5,129,564 | 92,150 | N/A | 143,114 | N/A |
9/30/2014 | 4,689,861 | 7,758 | N/A | 185,717 | N/A |
6/30/2014 | 4,246,337 | 12,441 | N/A | 365,293 | N/A |
3/31/2014 | 3,800,856 | 47,971 | N/A | 374,591 | N/A |
12/31/2013 | 3,226,059 | -5,148 | N/A | 234,840 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei A028260 ( 8.4% per jaar) ligt boven de spaarquote ( 2.7% ).
Winst versus markt: De winst van A028260 ( 8.4% per jaar) zal naar verwachting langzamer groeien dan de markt KR ( 28% per jaar).
Hoge groeiwinsten: De winst van A028260 zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van A028260 ( 1.9% per jaar) zal naar verwachting langzamer groeien dan de markt KR ( 9.4% per jaar).
Hoge groei-inkomsten: De omzet van A028260 ( 1.9% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen A028260 zal naar verwachting over 3 jaar laag zijn ( 6.7 %).